POU5F1 and gastric cancer: The combined expression of NANOG with other CSC markers such as OCT-4, and SOX-2, and proliferation markers, such as KI-67 and PCNA, were better predictors of relapse in patients with gastric cancer, as demonstrated by Li et al. [22].